Back to top
more

Rite Aid Corporation (RAD)

(Delayed Data from NYSE)

$8.77 USD

8.77
1,437,900

-0.03 (-0.34%)

Updated May 3, 2019 04:02 PM ET

After-Market: $8.75 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Rite Aid (RAD) Expedites Transformation on Restructuring Plan

by Zacks Equity Research

Rite Aid's (RAD) new restructuring plan is likely to reduce debt, strengthen liquidity, accelerate store footprint optimization plan and divest Elixir Solutions to MedImpact.

Brian Bolan headshot

Bear of the Day: Walgreens Boots Alliance (WBA)

by Brian Bolan

Competition heated up and Walgreens got the boot.

Farmer Brothers (FARM) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Farmer Brothers (FARM) delivered earnings and revenue surprises of -37.70% and 0.35%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Rite Aid (RAD) Moves to Buy: Rationale Behind the Upgrade

by Zacks Equity Research

Rite Aid (RAD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Industry Outlook Highlights CVS Health, Herbalife, Rite Aid and Amazon

by Zacks Equity Research

CVS Health, Herbalife, Rite Aid and Amazon have been highlighted in this Industry Outlook article.

Urmimala Biswas headshot

3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds

by Urmimala Biswas

The Zacks Retail Pharmacy and Drugstore industry players like CVS, HLF and RAD are likely to gain despite reimbursement challenges hurting the overall industry health.

Can Rite Aid (RAD) Stock Bounce Back on Growth Endeavors?

by Zacks Equity Research

Despite drab demand and headwinds at Elixir Insurance, Rite Aid's (RAD) solid online show, strength in the Retail Pharmacy segment and cost-saving initiatives are likely to aid growth.

Rite Aid (RAD) Q1 Loss Narrower Than Expected, Revenues Beat

by Zacks Equity Research

Rite Aid's (RAD) Q1 results gain from solid pharmacy margins and progress in its turnaround program. Lower revenues from COVID-19 vaccines and testing, and store closures are headwinds.

Compared to Estimates, Rite Aid (RAD) Q1 Earnings: A Look at Key Metrics

by Zacks Equity Research

Although the revenue and EPS for Rite Aid (RAD) give a sense of how its business performed in the quarter ended May 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Rite Aid (RAD) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Rite Aid (RAD) delivered earnings and revenue surprises of 51.01% and 5.63%, respectively, for the quarter ended May 2023. Do the numbers hold clues to what lies ahead for the stock?

Walgreens Boots Alliance (WBA) Q3 Earnings Miss Estimates

by Zacks Equity Research

Walgreens (WBA) delivered earnings and revenue surprises of -5.66% and 4.82%, respectively, for the quarter ended May 2023. Do the numbers hold clues to what lies ahead for the stock?

Things Likely to Decide Rite Aid's (RAD) Fate in Q1 Earnings

by Zacks Equity Research

Rite Aid's (RAD) Q1 results are expected to reflect muted demand for flu immunizations and COVID-19 vaccines, the adverse impacts of closed stores and reduced Elixir insurance memberships.

Signet (SIG) Surpasses Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Signet (SIG) delivered earnings and revenue surprises of 23.61% and 2.27%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?

Rent the Runway, Inc. (RENT) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Rent the Runway, Inc. (RENT) delivered earnings and revenue surprises of 4.17% and 1.17%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Industry Outlook Highlights CVS Health, Walgreens BootsAlliance, Rite Aid and Amazon

by Zacks Equity Research

CVS Health, Walgreens BootsAlliance, Rite Aid and Amazon have been highlighted in this Industry Outlook article.

Urmimala Biswas headshot

3 Retail Pharmacy and Drugstore Stocks to Watch in a Growing Industry

by Urmimala Biswas

Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain on the strength of their digital pharmacies.

Rite Aid (RAD) Q4 Loss Wider Than Expected, Revenues Beat

by Zacks Equity Research

Rite Aid's (RAD) Q4 results gain from improvements in retail pharmacy and Elixir. However, lower revenues from COVID vaccines and testing, and store closures act as headwinds.

Rite Aid (RAD) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Rite Aid (RAD) delivered earnings and revenue surprises of -61.04% and 6.90%, respectively, for the quarter ended February 2023. Do the numbers hold clues to what lies ahead for the stock?

Factors Likely to Influence Rite Aid (RAD) in Q4 Earnings

by Zacks Equity Research

Higher non-COVID prescriptions, strength in PBM and delivery service expansion are likely to have impacted Rite Aid's (RAD) Q4 performance amid sluggishness in Retail Pharmacy and Pharmacy Services.

Walgreens Boots Alliance (WBA) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Walgreens (WBA) delivered earnings and revenue surprises of 5.45% and 4.16%, respectively, for the quarter ended February 2023. Do the numbers hold clues to what lies ahead for the stock?

Rite Aid (RAD) Down 23.5% in Three Months: Can it Rebound?

by Zacks Equity Research

Despite drab demand and supply-chain headwinds, Rite Aid's (RAD) online strength, led by expanded delivery services, increased non-COVID prescriptions and cost-saving initiatives, are likely to aid.

Zacks Industry Outlook Highlights CVS Health, Walgreens Boots Alliance, Rite Aid and Amazon

by Zacks Equity Research

CVS Health, Walgreens Boots Alliance, Rite Aid and Amazon are part of the Zacks Industry Outlook article.

Urmimala Biswas headshot

3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds

by Urmimala Biswas

The Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain despite reimbursement challenges hurting the overall industry health.

Why Is Rite Aid (RAD) Down 7% Since Last Earnings Report?

by Zacks Equity Research

Rite Aid (RAD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Can Rite Aid (RAD) Get Back on Track Via Solid Growth Efforts?

by Zacks Equity Research

Rite Aid (RAD) is reeling under elevated expenses. Yet, online strength, led by expanded delivery services, increased non-COVID prescriptions, and cost-saving initiatives, are likely to aid.